Kohl's represents good value for patient investors, says RW Baird Baird believes Kohl's represents good value for patient investors citing low expectations and several credible initiatives that are poised to drive comp improvement in the second half of the year. Shares are Outperform rated with a $63 price target.
News For KSS From The Last 14 Days
Check below for free stories on KSS the last two weeks.
Kohl's announces Juicy Couture now available at stores nationwide Kohlís announced that Juicy Couture is now available at Kohlís stores nationwide and Kohls.com/JuicyCouture. Kohlís is supporting the launch of Juicy Couture with a marketing campaign that includes a new partnership with Refinery29. For the first time, Kohlís is engaging the influential and popular online lifestyle destination to partner with key trend-setting bloggers and to host celebratory events. There will also be print, broadcast and digital advertising and social initiatives.
PVH Corp. says 'cautiously optimistic' about 2H14 PVH Corp. (PVH) sees continued momentum of 5% whole sale growth for the spring season in its Tommy Hilfiger business. Says seeing early signs of positive consumer reception in European and Asian markets in its jeans business. Says Heritage business seeing pressure from promotional retail environment, but the unit remains well positioned for "strong growth" in the future. Says Izod brand is set to launch at all major Kohls (KSS) stores. Believes that this launch will drive the company's turnaround plan in 2H14. Says "well positioned" for targeted earnings growth. Says August sales trends in Calvin Klein and Tommy Hilfiger are currently ahead of sales plan. Continues to see debt pay-downs on track for $400M for the year. Comments made during the company's Q2 earnings conference call.